Spyre Therapeutics, Inc. (SYRE) — S-1/A Filings
All S-1/A filings from Spyre Therapeutics, Inc.. Browse 4 S-1/A reports with AI-powered summaries and risk analysis.
S-1/A Filings (4)
-
Spyre Therapeutics Files S-1/A Amendment
— Mar 27, 2024 Risk:
Spyre Therapeutics, Inc. (SYRE) filed a Amended IPO Registration (S-1/A) with the SEC on March 27, 2024. Spyre Therapeutics, Inc. (formerly Aeglea BioTherapeuti -
Spyre Therapeutics, Inc. Files S-1/A Amendment
— Mar 14, 2024 Risk: medium
Spyre Therapeutics, Inc. (SYRE) filed a Amended IPO Registration (S-1/A) with the SEC on March 14, 2024. Spyre Therapeutics, Inc. filed an S-1/A amendment on Ma -
Spyre Therapeutics, Inc. Files S-1/A Amendment
— Mar 1, 2024 Risk: medium
Spyre Therapeutics, Inc. (SYRE) filed a Amended IPO Registration (S-1/A) with the SEC on March 1, 2024. Spyre Therapeutics, Inc. filed an S-1/A amendment on Mar -
Spyre Therapeutics, Inc. Files S-1/A Amendment
— Feb 5, 2024 Risk:
Spyre Therapeutics, Inc. (SYRE) filed a Amended IPO Registration (S-1/A) with the SEC on February 5, 2024. Spyre Therapeutics, Inc. filed an S-1/A amendment on
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX